A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation

This was a single-center, double-blinded, randomized, controlled cosmetic clinical trial to investigate the efficacy and tolerance of dark spot corrector serum and regimen skincare products when used over the course of 16 weeks by women with clinically determined moderate discrete hyperpigmentation (solar lentigines \[age spots/sun spots\]) on the global face, and self-perceived very bothersome hyperpigmentation (darkening), including spots, on the global face.

NCT Number	NCT07468175
Lead Sponsor	Revision Skincare
Conditions	Hyperpigmentation, Dark Spots
Enrollment	48 participants
Start Date	2024-10-21
Primary Completion	2025-03-13 (estimated)
Study Completion	2025-03-27 (estimated)
Updated on ClinicalTrials.gov	2026-03-12